Author(s):
Ravi Varala, Sudhakar Madhavedi
Email(s):
ravivarala@gmail.com
DOI:
10.52711/0974-4150.2023.00035 
Address:
Ravi Varala1*, Sudhakar Madhavedi2
1Scrips Pharma, Mallapur, Hyderabad-500 076, Telangana, India.
2Department of Management, Kshatriya College of Engineering, Nizamabad-503 224, Telangana, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 3,
Year - 2023
ABSTRACT:
Earlier than shielding the entire world from Covid-19, another crisis is looming around the globe due to the Monkeypox virus (MPXV). In recent times, the sudden rise of Monkeypox (MPX) epidemic cases is now a cause of concern for countries around the globe. Globally, the number of new weekly cases fell by 5% from November 14 to November 20, 2022. More than 62,000 confirmed cases have been reported to WHO from 105 countries and territories since the outbreak began few months ago, along with 23 fatalities. The current outbreak primarily affects guys who have sex with other men and is disseminated primarily via sexual contact. "Just because a condition like monkeypox seems manageable does not guarantee it will remain manageable." The poor dissimilation of knowledge about viral zoonosis, disease investigation, and scientific research about MPX outbreaks can deteriorate the current situation into a deep crisis in the near future. Hence, the present case study focuses on the origin, detection, investigation, prevention, and therapeutic measures of MPX disease in the rising situation of cases. In addition, it proposes various public health measures, policy actions to prevent the transmission of the virus, medical support, and scaling up infrastructure, which are the desperate needs of the hour.
Cite this article:
Ravi Varala, Sudhakar Madhavedi. Looming another global crisis-Monkeypox:Plan of action for third world countries. Asian Journal of Research in Chemistry 2023; 16(3):221-4. doi: 10.52711/0974-4150.2023.00035
Cite(Electronic):
Ravi Varala, Sudhakar Madhavedi. Looming another global crisis-Monkeypox:Plan of action for third world countries. Asian Journal of Research in Chemistry 2023; 16(3):221-4. doi: 10.52711/0974-4150.2023.00035 Available on: https://ajrconline.org/AbstractView.aspx?PID=2023-16-3-5
REFERENCES:
1. Adeiza S. Shuaibu A. Trends in Monkeypox Research: A Sixty Year Bibliometric Analysis. Microbes and Infectious Diseases. 2022; 3(3): 500-513
2. Isidro J. Borges V. Pinto M. Sobral D. et al Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat. Med. 2022; 28: 1569-1572. https://doi.org/10.1038/s41591-022-01907-y
3. Nigeria Centre for Disease Control and Prevention (NCDCP). Monkeypox monthly situational report, December 2019. [Cited 2020 Oct 1]. https://ncdc.gov.ng/themes/common/files/sitreps/5a1a9820f21136842ba43f186b8d09e7.pdf
4. https://www.gavi.org/vaccineswork/monkeypox-cases-waning-global-threat-remains?gclid=Cj0KCQiAnNacBhDvARIsABnDa6_g8xkbFPwQvNtYCbIL_d5R0XNHiHAi0jtPxStoMiwmU0_QnJJzt0gaAn_fEALw_wcB
5. Nolen L. D. Osadebe L. Katomba J. Likofata J. Mukadi D. et al Introduction of monkeypox into a community and household: risk factors and zoonotic reservoirs in the Democratic Republic of the Congo. The American Journal of Tropical Medicine and Hygiene. 2015; 93(2): 410-415
6. Nguyen P. Y. Ajisegiri W. S. Costantino V. Chughtai A. A. MacIntyre C. R. Reemergence of human monkeypox and declining population Immunity in the context of urbanization, Nigeria, 2017-2020. Emerging Infectious Diseases. 2021; 27(4): 1007-1014
7. Heymann D. L. Szczeniowski M. Esteves, K. Re-emergence of monkeypox in Africa: a review of the past six years. British Medical Bulletin. 1998; 54(3): 693-702
8. Centre for Disease Control & Prevention (2022), Treatment Information for Healthcare Professionals. Retrieved on July 28, 2022
9. Sklenovska, N. and Van Ranst, M., Emergence of monkeypox as the most important orthopoxvirus infection in humans. Frontiers in Public Health. 2018; 6: 241
10. Manes N. P. Estep R. D. Mottaz H. M. Moore R. J. et al Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions. Journal of Proteome Research. 2008; 7(3): 960-968
11. Schneider K. A. Eichner M. Does it matter who is spreading monkeypox?. The Lancet Infectious Diseases 2022; 22(9): P1266-P1267. https://doi.org/10.1016/S1473-3099(22)00431-5
12. Mint. Monkeypox spreading in vulnerable groups including children warns WHO. Retrieved on July 28, 2022 https://www.livemint.com/news/world/monkeypox-spreading-in-vulnerable-groups-including-children-warns-who-11656511084309.html
13. Brown K. Leggat P. A. Human monkeypox: current state of knowledge and implications for the future. Tropical Medicine and Infectious Disease. 2016; 1(1): 8
14. Varala R. Dubasi N. Madhavedi S. Status of Pharmaceutical Patents during COVID-19 Pandemic. Caribbean Journal of Sciences and Technology. 2022; 10(1): 16-19.
15. Vijay K. Madhavedi S. Varala R. Covid-19 Pandemic: Is it a Challenge or Opportunity for Pharmaceutical Industry around the Globe? J Pharmaceutics and Pharmacology Research. 2022; 5(7): 1-3. 10.31579/2693-7247/089
16. Kurra M. Narsimhaswamy D. Varala R. n-Covid Drugs and their Relevance in Present Day Scenario. Acta Scientific Pharmaceutical Sciences 6 (1), 113-115. 10.31080/ASPS.2022.06.0841
17. Sekharan C. B. Varala R. COVID-19 Vaccines Across the Globe-A Study. Caribbean J. Sci. Tech. 9 (1), 10-12. 10.55434/CBI.2021.9110
18. Varala R. Bollikolla H. nCovid-19 in 2020: From despair to Hope. Coronaviruses 1 (1), 9-12. 10.2174/2666796701999200621202839
19. Samarpita P. Concerns regarding COVID-19 outbreak among healthcare workers. Asian Journal of Nursing Education and Research. 2022; 12(3):325-9. 10.52711/2349-2996.2022.00067
20. Manisha R. Pradnya K. Coronavirus Disease: A Review of a New Threat to Public Health. Asian J. Pharm. Res. 2020; 10(3):241-244. 10.5958/2231-5691.2020.00042.8
21. Archana B. Chavhan, Pavan S. Jadhav, Satish Shelke. COVID 19: Outbreak, Structure and Current therapeutic strategies. Asian J. Pharm. Tech. 2021; 11(1):76-83. 10.5958/2231-5713.2021.00013.1
22. Ritika Rocque. Bioterrorism: Are we ready for such health care emergencies?. Int. J. Nur. Edu. and Research. 2020; 8(4):554-558. 10.5958/2454-2660.2020.00122.2
23. Rahul S. T. Sopan N. N., Premnath M. S., Minal R. P. Ashwini G. P. Pravin O. P. Historical Dilemmas of Coronavirus Disease (COVID-19): Public health emergency, Management perspectives and Global impacts. International Journal of Nursing Education and Research. 2021; 9(3):345-6. 10.52711/2454-2660.2021.00080
24. Emy J. Rani J. Monkeypox: All you need to know about Monkey Pox. International Journal of Nursing Education and Research. 2022; 10(4):409-4. 10.52711/2454-2660.2022.00093
25. Hindustan A. A. Chinthaginjala H. Ksheerasagare T. Jyothi V. K. Ganthala A. K. Amminga S. T. T. Vitiating Ebola Outbreak: A Brief Guide to the Humanity. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(2):153-6. 10.52711/0975-4377.2021.00027
26. Nabi Y. A. A. Gulnara T. N. I. Daniyar S. Assessment of the Integration between Primary Health Care and Public Health in Almaty. Research J. Pharm. and Tech 2019; 12(9):4241-4249. 10.5958/0974-360X.2019.00729.7
27. Ankita S. Vinit S. B. Zoonosis and Bats: Evolution of Virulence and Disease Outbreaks. Research Journal of Pharmacy and Technology. 2022; 15(4):1877-2. 10.52711/0974-360X.2022.00314
28. Akshada G. W. Dattaprasad N. V. Ravindra S. J. Ganesh S. S. The ongoing Pharmacotherapy for ministration of Covid 19 disease: A Review. Research Journal of Science and Technology. 2022; 14(1):66-2. 10.52711/2349-2988.2022.00010